|Bid||11.06 x 0|
|Ask||11.09 x 0|
|Day's Range||10.95 - 11.30|
|52 Week Range||4.11 - 11.30|
|Beta (3Y Monthly)||4.35|
|PE Ratio (TTM)||34.98|
|Earnings Date||Jul 27, 2017 - Jul 28, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.83|
Organigram Holdings (TSX VENTURE: OGI) (OTCQX: OGRMF) is betting big on adult-use cannabis edibles with investing in a fully-automated production line having the ability to produce chocolate cannabis edibles. The parent company of licensed producer of cannabis Organigram unveiled plans to invest $15 million in the production line that could produce an estimated 4 million kilograms of chocolate cannabis edibles […]The post Organigram Investing $15M in Chocolate Cannabis Production Facility appeared first on Market Exclusive.
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, ...
MONCTON , May 17, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that its common shares will commence trading on the Nasdaq Global Select Market under the symbol "OGI" on Tuesday May 21, 2019 . Organigram's common shares will continue to be listed and trade on the Toronto Venture Exchange (TSXV), also under the symbol "OGI".
MONCTON, NB , May 13, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis is pleased to announce the recent appointment of government relations expert Cameron Bishop as the Company's Vice President, Public Affairs and Stakeholder Relations ( North America ).
Organigram Holdings Inc. sold the second-most amount of recreational cannabis in Canada, but its market capitalization trails rivals handily — at least until it lists on the Nasdaq and gets access to more institutional investors.
VIVO Cannabis (TSX-V: VIVO) (OTCQX: VVCIF) reported its fourth quarter and 2018 annual financial and operating results. The company had net sales of C$9.7 million for 2018, versus net sales of C$0.9 million for 2017. Net revenue for the fourth quarter was C$5.8 million, up from C$0.3 million in the same quarter of 2017. The Green Organic Dutchman […]The post Cannabis Stock News Daily Roundup April 30 appeared first on Market Exclusive.
MONCTON, NB , April 30, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis is pleased to announce that it has received an expanded cultivation license from Health Canada in line with its previously announced Phase 4A and 4B expansion plans for its Moncton Campus.
MONCTON, NB , April 26, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that it has applied to list its common shares on the NASDAQ Global Select Market ("NASDAQ"). In advance of anticipated listing on the NASDAQ, Organigram will file a Form 40-F Registration Statement with the United States Securities and Exchange Commission. The listing of the Company's common shares on the NASDAQ remains subject to the approval of the NASDAQ and the satisfaction of all applicable listing and regulatory requirements. The Company will continue to maintain the listing of its common shares on the TSX Venture Exchange under the symbol "OGI".
As an investor, I look for investments which does not compromise one fundamental factor for another. By this I mean, I look at stocks holistically, from their financial health to their future outlook. In the case of OrganiGram Holdings...
Cannabis stocks rose across the board on Tuesday, as three separate surveys found Americans are increasingly in favor of legalization, demonstrating a major shift in opinion over the last two decades.
Chevron Up $9.5B in Ruling to Negate Ruling to Force it to Pay $9.5B to Ecuador Prepare for a series of confusing negations of double and triple negatives. The case involves Chevron (NYSE:CVX) and Ecuador, generally in the news these days after the arrest of Julian Assange. This time they’re in the news for their […]The post Market Morning: Chevron Beats Ecuador, Sanders Winning, Volkswagen Losing, Pot Delivery Problems appeared first on Market Exclusive.
Organigram on Monday joined a chorus of companies saying their challenge in supplying the Canadian cannabis market is not growing massive amounts of marijuana, but transforming the plant into a product that’s ready for sale.
Neptune Wellness Solutions (NASDAQ: NEPT) (TSX: NEPT) announced that its Solutions Business has started offering product development solutions with hemp-derived ingredients to business customers in the U.S. A U.S.-based supply chain of licensed hemp extract producers has been established, and initial purchase orders are now being processed, the company said in a statement this morning. BLOCKSTRAIN […]The post Cannabis Stock News Daily Roundup April 15 appeared first on Market Exclusive.
Canadian cannabis company Organigram Holdings Inc. said Monday it had a net loss of C$6.4 million ($4.8 million), or 5 cents a share, in its fiscal second quarter to Feb. 28, after earnings of C$1.076 million, or 1 cent a share, in the year-earlier period. Gross revenue rose to C$33.5 million from C$2.93 million a year ago. Revenue excluding excise taxes came to C$26.9 million. The consensus of four analysts polled by FactSet was for EPS of 2 cents and revenue of C$24.2 million. The company said its "all-in" cost of cultivation came to 85 cents per gram of dried flower harvested, down from C$1.48 a year ago, mostly due to higher yields per plant. The company said it believes it's well positioned for the derivatives and edibles launch in the fall of 2019 and is expanding capacity at its Moncton facility. It is focusing on vaporizable pen technologies and a range of edibles. Shares rose 0.9% premarket, and have gained 129.3% in the last 12 months, while the S&P 500 has gained 9.5%.
Organigram Reports Second Quarter Fiscal 2019 Results; Record Net Revenue of $26.9 Million
MONCTON, NB , April 7, 2019 /CNW/ – Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis is pleased to announce the recent appointment of strategy and operations consultant James Cavanagh as the Company's Chief of Staff. Mr. Cavanagh will work directly with all executive team members to help ensure corporate priorities are maintained while identifying procedural efficiencies.
HOUSTON, TX / ACCESSWIRE / April 4, 2019 / Over the next decade, spending on worldwide cannabis could reach $57 billion by 2027, according to Arcview Market Research and BDS Analytics. In their report, ...
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks concludes our two part series looking at the Canadian cannabis landscape and the numerous companies ensuring not only a brick and mortar footprint, but also creating a significant online e-commerce presence as well. With the many supply shortages the Canadian cannabis market has faced since legalization last year, having the store’s menus and the capability of reserving products online for pickup just might be the way for Canadian cannabis consumers to beat the low inventory situation. Grab, a new legal cannabis app based in Canada, is set to launch in the Alberta and Ontario markets this April.
MONCTON, NB , April 3, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis is pleased to announce the release of a cross-platform patient-focused mobile application (the "Organigram Mobile App" or the "Application"). The Application was designed to offer patients greater convenience in optimizing their medication regimen and stay up-to-date on products, programs and Company news.